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2Internship Project and Role
As a DHS intern at Lawrence Livermore National Laboratory (LLNL), I was a member 
of the Agricultural Domestic Demonstration and Application Program (AgDDAP) under 
the mentorship of Benjamin Hindson. This group is focused on developing assays for the 
rapid detection of animal diseases that threaten agriculture in the United States. 
The introduction of a foreign animal disease to the US could potentially result in 
devastating economic losses. The 2001 Foot-and-Mouth Disease (FMD) outbreak in the 
UK cost over 20 billion dollars and resulted in the death of over 6 million animals. FMD 
virus is considered to be one of greatest threats to agriculture due to its high infectivity, 
robustness, and broad species range. Thus, export of meat and animal products from 
FMD endemic countries is strictly regulated. Although the disease is rarely fatal in adult 
animals, morbidity is close to 100%. FMD also causes overall production (i.e. milk, 
mass) to decrease dramatically and can reduce it permanently. 
The rapid and accurate diagnosis of FMD and other foreign animal diseases is essential to 
prevent these diseases from spreading and becoming endemic to the country. Every hour 
delay in the detection of FMD is estimated to cost up to 3 million dollars. Diagnosis of 
FMD is often complicated by other diseases manifesting similar symptoms in the animal, 
such as vesicular stomatitis, bluetongue, etc. Typically, diagnosis cannot be made by 
clinical signs alone and samples must be sent away for testing. Depending on the test, 
such as in virus isolation, this can take several days.
3AgDDAP had previously developed a high-throughput multiplexed polymerase chain 
reaction (PCR) assay for the rule-out of Foot-and-Mouth Disease and six other look-a-
like diseases. This assay is intended for use in FMD surveillance, differential diagnosis in 
an outbreak scenario, and to establish an FMD-clean state after an outbreak. PCR based 
assays are favorable for multiple reasons. Viral nucleic acids can be detected in samples 
several days before clinical signs appear. PCR is quick with results available in a few 
hours. The ability to multiplex PCR allows many different diseases to be detected. Also 
multiple signatures can be detected for each disease, decreasing the likelihood of a false 
negative result due to viral mutation. The virus would have to obtain multiple mutations 
in the correct areas in the genome to escape detection. PCR can also be easily automated 
with robotics and made high-throughput, allowing close to a hundred samples to be 
processed at a time with minimal chance of cross over contamination. 
This assay panel will be expanded in the future to screen for more diseases and also be
separated into specific panels targeted at bovine, ovine, and porcine diseases. The assay is 
designed to be deeply multiplexed and could potentially screen for as many as 96
different diseases. The assay will also be modified to accept different types of sample 
matrices, including blood, milk, and tissues. This is necessary because the presence of 
viral nucleic acids in a particular sample matrix can be dependent on the virus, the stage 
of infection, and the species infected. 
My part of the project was to develop protocols for the purification of viral nucleic acids 
from blood, milk, serum, and plasma. Previous work had identified a sufficient protocol 
4for the purification of viral nucleic acids from an oral swab in viral transport media 
(VTM.) Purification and detection of nucleic acids from complex sample matrices can be 
complicated by the presence of other macromolecules and inorganic compounds. Thus, 
we wanted to assess the performance of a commercially available nucleic acid isolation 
kit to purify viral nucleic acids from such sample matrices. The Ambion MagMAX-96 
Viral Nucleic Acid Isolation Kit was used to purify viral nucleic acids and TaqMan 
reverse-transcriptase PCR (RT-PCR) was used to quantify the nucleic acid output. 
Purified live bovine viral diarrhea (BVD) virus was also spiked into the sample matrices 
and assessed via TaqMan RT-PCR.
Alien arRNA is a synthetic RNA sequence packaged in a non-infectious MS9 phage and 
was used to simulate live virus. The RNA sequence does not match any in GenBank, 
hence the name “alien.” Direct spikes of alien arRNA into the PCR mix showed that 
TaqMan RT-PCR was sensitive down to 10 copies of alien RNA per reaction. 
Alien arRNA was also spiked into serum, plasma, viral transport media (which contained 
an oral swab), whole blood (heparin and EDTA), and raw milk. It was found that 
purifying alien RNA from serum, plasma, and oral swabs placed in viral transport media 
(VTM) gave consistent yields. This result suggested that purification of viral nucleic 
acids from serum and plasma should perform similarly to oral swabs in VTM. 
Purification of alien RNA from whole blood and raw milk samples proved to be less 
reproducible due to interference from cellular DNA (i.e. mitochondrial DNA in red blood 
cells and genomic DNA in somatic cells of milk.) Large differences in the quantity of 
5purified RNA were detected. Too much cellular DNA in the sample may reduce viral 
nucleic acid yield. Use of a different kit that removed cellular DNA (through a DNase 
treatment) improved RNA recovery. 
Live BVD virus (20 – 200 TCID50/mL) was spiked into VTM, serum, whole blood, and 
raw milk and nucleic acids were purified and detected with TaqMan RT-PCR. Previous 
work has shown that this concentration range falls around the threshold median 
fluorescence intensity (MFI) in multiplex PCR. An MFI above this threshold value is 
indicative of a sample positive for BVD. TaqMan RT-PCR was sensitive down to 20 
TCID50/mL in VTM, though sensitivity varied in serum, whole blood, and raw milk. 
Purification of BVD RNA from serum, whole blood, and milk did not produce a 
consistent yield. This was expected of whole blood and milk due to the presence of 
cellular DNA. However, inconsistency was not expected from serum since its 
performance with alien RNA was similar to oral swab in VTM. This inconsistency may 
be due to degradation of the viral stock. Since the viral stock was not re-titred prior to the 
experiment, it cannot be determined if the virus is still intact or at the correct titre.
Protocols for purification of viral nucleic acid from whole blood and raw milk need to be 
further optimized to improve reproducibility. More work on nucleic acid purifications 
with spiked live virus need to be completed. However, based on the alien RNA 
purifications from serum and plasma, live virus nucleic acid purifications from these 
sample matrices should perform well. Future work will also include purification of 
6nucleic acids from other live viruses in the same sample matrices and detection via 
multiplex PCR. 
The results from this project were partially presented at the LLNL Summer Student 
Poster Symposium on August 10, 2006. These results will also be published in a report
submitted to the USDA and DHS. 
Internship Impact on Career Planning
Interning at LLNL has given me the opportunity to experience research in a government 
setting. I have been in academic research for the past five years and have had limited 
experience in the government arena. I have thought about pursuing a career in 
government research and I have enjoyed the chance to work at LLNL. It has been 
extremely exciting to see the talents of many people from different disciplines come 
together and create not only new ideas but carry them through to actual products. One of 
my interests has been in developing diagnostics for the detection of animal and/or human 
disease. I was lucky to be able to work on a project doing just that.
I was extremely fortunate to be able to attend a demonstration of the high-throughput 
capabilities of the AgDDAP multiplexed PCR assay at the Diagnostic Laboratory of 
Colorado State University. It is hoped that this assay will eventually become a standard 
procedure for animal disease testing at diagnostic laboratories around the nation. 
AgDDAP members, staff from DHS, USDA, and diagnostic laboratories, and industry 
members gathered in Fort Collins to observe the capabilities of the assay and share ideas 
7of where this technology may go. This was the first time I was actually able to observe 
the assay being carried out from nucleic acid isolation through detection using the 
robotics. I was also able to see how many different people with different expertise, 
ranging from molecular biology to computer science, had to work together to develop this 
product. I also had the opportunity to see how people on the receiving end of the product 
reacted and what questions and concerns they had. 
The DHS seminars and tours of LLNL facilities gave an overview of other projects 
occurring at LLNL. It is very easy in such a large facility and in science to get too 
focused in your specific area. Having these seminars and tours allowed me to step back 
and take a look at the bigger picture of what people are doing to defend the US. 
The different lectures I attended were mostly from non-LLNL scientists. It was 
interesting to see how collaborations could be formed between government and 
academia. It was also a good reminder that basic science research is very important to 
continue to feed the development of technologies and products. 
LLNL did an excellent job bringing together all of the summer interns. All of the summer 
interns, regardless of the program they were affiliated with, were invited to various 
lectures, workshops, and socials. It was a great way to meet people from various fields 
and at different stages of their education. Students early in their education, some as early 
as high school, benefited from the ability to interact with older students. Working in a lab 
at LLNL, in itself, is very conducive to mixing diverse people since many of the labs are 
8shared between multiple groups. I enjoyed being able to interact with post-doctoral 
students and other graduate students to develop ideas for where I might go and what I 
might do after graduate school. I also enjoyed being around the undergraduates and 
serving as a resource for graduate school life. 
Areas of research to accomplish DHS mission and goals
It is important that basic research at the university and government level is continually 
funded. It is through basic research that novel ideas can be developed and used as the 
basis for new technology. New technologies enable us to defend our borders, prevent acts 
of terrorism and, if need be, respond to them.  Funding basic research at the university 
levels also provides the support needed to train tomorrow’s leaders. As a graduate 
student, I am very appreciative of the funding from DHS to continue my education. I 
hope that I can continue to support the DHS mission in my future career, whatever it may 
be. 
Lectures and Activities Attended
AgDDAP meetings and events:
June 28, 2006: Lab meeting
July 7, 2006: Sample collection, B&G Dairy, Davis, CA
July 27, 2006: AgDDAP High-throughput Demonstration, Diagnostic Laboratory, 
Colorado State University Veterinary Teaching Hospital, Fort Collins, CO
DHS Seminar series:
June 20, 2006: Tony Farmer: Terrorism and Terrorism Network
9July 18, 2006: Reg Beer: Microdroplet PCR
August 1, 2006: Kevin Ness: Microfluidic technologies to purify, concentrate and 
separate biological samples
August 8, 2006: Ellen Raber: Restoration and Decontamination
Symposiums
August 10, 2006: LLNL Student Poster Session; Presented poster entitled: 
Nucleic Acid Purification from Clinical Sample Matrices for Foot-and-
Mouth Disease Diagnostics 
Lectures and Panels
June 22, 2006: Panel – Hot Topics in Science: What’s next?
Moderator: Eveline Dube, Division Leader, CAR, Computation
Elbert Branscomb , Associate Director, Biosciences
Anantha Krishnan, Director, Micro/Nano Technology Center, Engineering
Edward Moses, Associate Director, NIF
Mark Musculus, Combustion Research Facility, SNL
June 29, 2006: Seminar: Evaluation of Nondestructive Technologies
July 21, 2006: Dr. Joseph DeRisi, Viral Discovery Chip, University of California, 
San Francisco
August 14, 2006: Biosecurity lecture: Dr. Robert Nordgren- Use of Recombinant 
Vaccines in Animal Health
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August 17, 2006: Biosciences Seminar: Dr. David J. Brenner, Columbia 
University: Minimally-Invasive, Very High Throughput Radiation Biosimetry 
after a Radiological Event
August 21, 2006: Biosciences Seminar: Dr. Michael Mahan, UC Santa Barbara –
Cross-Protective Vaccines for Emerging Infectious Diseases
Tours
June 29, 2006: LLNL Library Tour and Orientation
July 11, 2006: National Ignition Facility, LLNL
August 2, 2006: Joint Genome Institute
Networking
June 24, 2006: LLNL River Rafting Trip
June 29, 2006: Student Welcome Reception
